Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) regimen as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (gisl)

Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) regimen as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (gisl) / Di Renzo, N; Brugiatelli, M; Montanini, A; Dell'Olio, M; Petrini, M; Stelitano, C; Liberati, Alessandro; Luminari, Stefano; Morandi, S; Giglio, G; Federico, Massimo. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 16:(2005), pp. 182-182.